Company no. 04862177 Charity no. 1100518
Transform Drug Policy Foundation Report and Unaudited Financial Statements 31 March 2023
Transform Drug Policy Foundation
Reference and administrative details
For the year ended 31 March 2023
Company number 04862177 Charity number 1100518 Registered office and The Station operational address Silver Street Bristol BS1 2AG
Trustees
Trustees, who are also directors under company law, who served during the year and up to the date of this report were as follows:
Nina Edmonds Katrina Ffrench Jane Hickman Nadia Islam Jay Jackson Howard Jacobs Jason Kew Rowan Miller Hannah Slater Victoria Unwin
Resigned 8 September 2022 Appointed 4 May 2023 Appointed 4 May 2023 Resigned 14 December 2022 Appointed 4 May 2023
Chief Executive Officer Alex Feis-Bryce
Independent examiners
Godfrey Wilson Limited Chartered accountants and statutory auditors 5th Floor Mariner House 62 Prince Street Bristol BS1 4QD
1
Transform Drug Policy Foundation
Report of the trustees
For the year ended 31 March 2023
The trustees present their report and accounts for the year ended 31 March 2023. Reference and administrative information set out on page 1 forms part of this report. The financial statements comply with current statutory requirements, the Memorandum and Articles of Association and the Statement of Recommended Practice - Accounting and Reporting by Charities (effective from January 2019).
Structure, governance and management
Governing document
Transform Drug Policy Foundation is a charitable company limited by guarantee (company number 04862177) and registered as a charity (charity number 1100518). The company was established under a Memorandum of Association and is governed by its Articles of Association. In the event of the company being wound up members are required to contribute an amount not exceeding £1. Its registered office is The Station, Silver Street, Bristol, BS1 2AG.
Risk management and assessment
The trustees are aware of their responsibilities to conduct a thorough risk assessment of the charity’s activities.
Currently risks are identified and controlled through a process of management overview of financial, managerial and strategic issues, coupled with frequent staff discussion and maintained in a risk register.
Appointment of trustees
The trustees who are directors for the purpose of company law and trustees for the purpose of charity law, who served for the year and up to the date of this report are set out on page 1. New trustees are appointed upon the recommendation of existing trustees and may involve external recruitment efforts using pro bono professional advice.
Organisational structure
Day to day responsibility for the provision of services rests with the Chief Executive Officer Alex FeisBryce.
Objectives and activities for the public benefit
The trustees have had regard to the guidance issued by the Charity Commission on public benefit.
The charity's activities during the year were the advancement of the education of the public and organisations in drug policy by research and dissemination of information, with a view to increasing the effectiveness of such policy and to preserve and safeguard the interests of the public. All our work is driven by the need to improve policy so that it better protects people according to reputable evidence.
Key achievements over the past year
Another successful year for Transform was underpinned by the culmination of a process to refresh our strategy. This has brought renewed clarity of purpose to Transform’s activity and improvements to how we communicate our vision.
Transform continues to push for a review of drugs legislation at the highest levels. We gave evidence to the Home Affairs Select Committee drugs inquiry and look forward to working with and advising the London Drugs Commission. We worked closely with Scottish Police, politicians and civil service to support activity for divergence in Scotland away from Westminster’s drug policies.
2
Transform Drug Policy Foundation
Report of the trustees
For the year ended 31 March 2023
We were delighted to resume our in-person annual lobby of Parliament by Anyone’s Child members in June, following hiatus due to coronavirus. Meetings were held with a wide range of MPs across political parties and it was inspiring to once again be able to bring together in person our activists and families, many of whom have been isolated during the pandemic.
Anyone’s Child held ‘Take Drugs Seriously’ public events in Birmingham, Newcastle, Edinburgh, London, Calderdale and Aberdare, bringing together local communities, police, councils, and Anyone’s Child activists for grown-up conversations about drugs policy. We know that these events are catalysts for localities to consider and implement alternative approaches to drug policy, as best as they are able to within the confines of UK law. These nascent changes further demonstrate the effectiveness of those with lived experience of the harms of UK drugs policy calling for change - our incredible network of Anyone’s Child families and activists.
The global momentum for cannabis legalisation and regulation has continued to progress this year, and Transform remains a key driver behind this. Transform has advised officials in Malta, Luxembourg, the Netherlands, Czech Republic, Germany, Brazil and Colombia on cannabis regulation. With demand growing for our insight, our How to Regulate Cannabis book has been translated into Spanish, Portuguese, Czech and German.
Transform visited New York, with our Blaksox allies, on the one year anniversary of the passing of the legislation to legally regulate cannabis in the state. The visit involved meeting key players involved in bringing about and shaping the reforms, from grassroots campaigners, to entrepreneurs and legislators tasked with implementing the new social justice measures.
Our innovative allyship with Blaksox, funded by Trust for London, which helps to ensure that Black communities are central to the debate on drug policy reform in the UK, continues to develop. As part of this work we held a number of drug policy discussions in London barber shops and were delighted to hold a community event in Hackney with Kassandra Frederique, Executive Director of the USbased Drug Policy Alliance.
We have continued our work at the local and regional levels to deliver life-saving measures within communities, which also help to progress the national and international debate on drug law reform. The Overdose Prevention Centre (OPC) ambulance, previously used in Glasgow without authorisation, has continued to be a key engagement tool for our work in local communities, with politicians and the media. In June, we took the ambulance to the Houses of Parliament and Welsh Senedd. This gave us the opportunity to demonstrate the life-saving impact of OPCs to key politicians, and engage with them on Transform’s work more broadly.
We have worked with a new network of homeless housing providers promoting formal tolerance of use policies in hostels, as a form of quasi-supervised consumption. One charity which we connected to existing providers using this approach has reduced overdose deaths in their properties from 21 in 2020, to zero deaths in 2022. The number of drug offence diversion schemes, where police replace arrests and criminal charges with diversion into education or support, continues to grow in the UK, with over a dozen forces and the whole of Scotland now using them.
3
Transform Drug Policy Foundation
Report of the trustees
For the year ended 31 March 2023
Thanks to dedicated funding, Transform was able to hold a two day event on drug policy reform at St George’s House in Windsor, engaging attendees from the Church of England, the Methodist Church, the Baptist Church and the Catholic Church. Focused discussions were challenging, enlightening and constructive. This important event was vital for speaking to new audiences and we are delighted that attendees will take the drug policy reform conversation forward with their own communities, recognising the moral and human imperative of a more compassionate, just and effective approach to drugs. Following on from this, we held a successful event in Newcastle Cathedral attended by over 100 people including key local stakeholders. We will continue to build on the foundations laid by this important work.
Finally, after many years on King Street, the Transform team settled into new, smaller premises at The Station in central Bristol.
We give our thanks to Transform’s funders and donors who continue to support our work in these uncertain times, along with our activists, volunteers and supporters. While our mission is ambitious, we remain committed to our vision of a world where drug policy protects people from harm. This year we were delighted to see indications of progress on this path, and to play our own part in bringing about change.
Financial review
During the year we successfully maintained our funding base via individual donations and continued funding from trusts and foundations. We remained at a similar size to previous years. We are financially secure but continue to seek out new sources of investment to ensure our financial position is sustainable.
Results
The results are shown on the Income and Expenditure Account.
Volunteers
During the year volunteers donated their services to the charity. The trustees estimate that these services in kind had a value of the order of £6,300.
Funders
Funds are received via grant-making trusts and from donations made by a wide range of individuals in the form of monthly direct debits, one-off payments, gifts in kind and larger donations made annually or several times a year. Donations are also collected at special events.
Reserves policy
The trustees have examined the charity’s requirements for reserves in light of the main risks to the organisation. It has established a policy whereby a designated fund should be established to meet: the working capital requirements of the charity for a period of 3 months in case future grants are not forthcoming; statutory payments liabilities for all staff; other liabilities. An amount of £126,000 has been maintained from unrestricted funds for this purpose, held in cash at the bank. Full details are set out in our Reserves and Investment Policy.
4
Transform Drug Policy Foundation
Report of the trustees
For the year ended 31 March 2023
Statement of responsibilities of the trustees
The trustees (who are also directors of the charity for the purposes of company law) are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
Company law requires the trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charity and of the income and expenditure of the charity for that period. In preparing those financial statements the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP;
-
make judgements and accounting estimates that are reasonable and prudent;
-
▪ state whether applicable accounting standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.
The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and which enable them to ensure that the financial statements comply with the Companies Act 2006. The trustees are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees confirm that to the best of their knowledge there is no information relevant to the examination of which the independent examiners are unaware. The trustees also confirm that they have taken all necessary steps to ensure that they themselves are aware of all relevant examination information and that this information has been communicated to the independent examiners.
Members of the charity guarantee to contribute an amount not exceeding £1 to the assets of the charity in the event of winding up. The trustees are members of the charity but this entitles them only to voting rights. The trustees have no beneficial interest in the charity.
Independent examiners
Godfrey Wilson Limited were re-appointed as independent examiners to the charitable company during the year and have expressed their willingness to continue in that capacity.
Approved by the trustees on 6 December 2023 and signed on their behalf by
Vicky Unwin
Victoria Unwin - Chair
5
Independent examiner's report
To the trustees of
Transform Drug Policy Foundation
I report to the trustees on my examination of the accounts of Transform Drug Policy Foundation (the charitable company) for the year ended 31 March 2023, which are set out on pages 7 to 19.
Responsibilities and basis of report
As the trustees of the charitable company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).
Having satisfied myself that the accounts of the charitable company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charitable company's accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
Independent examiner’s statement
Since the charitable company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales (ICAEW), which is one of the listed bodies.
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
(1) accounting records were not kept in respect of the charitable company as required by section 386 of the 2006 Act; or
-
(2) the accounts do not accord with those records; or
-
(3) the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view' which is not a matter considered as part of an independent examination; or
-
(4) the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
William Guy Blake
Date: 8 December 2023 William Guy Blake ACA Member of the ICAEW For and on behalf of: Godfrey Wilson Limited Chartered accountants and statutory auditors 5th Floor Mariner House 62 Prince Street Bristol BS1 4QD
6
Transform Drug Policy Foundation
Statement of financial activities (incorporating an income and expenditure account)
For the year ended 31 March 2023
| Restricted Note £ Income from: Donations 3 91,827 Charitable activities 4 - Investments - Total income 91,827 Expenditure on: Raising funds - Charitable activities 116,007 Total expenditure 5 116,007 Net income / (expenditure) (24,180) Transfers between funds - Net movement in funds 6 (24,180) Reconciliation of funds: Total funds brought forward 74,893 Total funds carried forward 50,713 |
Unrestricted £ 266,664 3,976 751 271,391 12,740 285,641 298,381 (26,990) - (26,990) 360,077 333,087 |
2023 Total £ 358,491 3,976 751 363,218 12,740 401,648 414,388 (51,170) - (51,170) 434,970 383,800 |
2022 Total £ 456,759 1,798 153 |
|---|---|---|---|
| 458,710 | |||
| 10,469 362,681 |
|||
| 373,150 | |||
| 85,560 - |
|||
| 85,560 349,410 |
|||
| 434,970 |
All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. Movements in funds are disclosed in Note 12 to the accounts.
7
Transform Drug Policy Foundation
Balance sheet
As at 31 March 2023
| Note Current assets Debtors 9 Cash at bank and in hand Liabilities Creditors: amounts falling due within 1 year 10 Net current assets Net assets 11 Funds 12 Restricted funds Unrestricted funds Designated funds General funds Total charity funds |
£ 5,028 395,458 |
2023 £ 400,486 (16,686) 383,800 383,800 50,713 321,302 11,785 383,800 |
2022 £ 4,939 508,488 |
|---|---|---|---|
| 513,427 (78,457) |
|||
| 434,970 | |||
| 434,970 | |||
| 74,893 292,670 67,407 |
|||
| 434,970 |
The directors are satisfied that the company is entitled to exemption from the provisions of the Companies Act 2006 (the Act) relating to the audit of the financial statements for the year by virtue of section 477(2), and that no member or members have requested an audit pursuant to section 476 of the Act.
The directors acknowledge their responsibilities for:
-
(i) ensuring that the Company keeps proper accounting records which comply with section 386 of the Act; and
-
(ii) preparing financial statements which give a true and fair view of the state of affairs of the Company as at the end of the financial year and of its profit or loss for the financial year in accordance with the requirements of section 393, and which otherwise comply with the requirements of the Act relating to financial statements, so far as applicable to the company.
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies' regime.
Approved by the trustees on 6 December 2023 and signed on their behalf by
Vicky Unwin
Victoria Unwin - Chair
8
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
1. Accounting policies
a) Basis of preparation
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities in preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Transform Drug Policy Foundation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note.
b) Going concern basis of accounting
- The accounts have been prepared on the assumption that the charity is able to continue as a going concern, which the trustees consider appropriate having regard to the current level of unrestricted reserves. There are no material uncertainties about the charity's ability to continue as a going concern.
c) Income
Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the item of income have been met, it is probable that the income will be received and the amount can be measured reliably.
Income from the government and other grants, whether 'capital' grants or 'revenue' grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.
d) Donated services and facilities
Donated professional services and donated facilities are recognised as income when the charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use by the charity of the item, is probable and the economic benefit can be measured reliably. In accordance with the Charities SORP (FRS 102), general volunteer time is not recognised.
On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.
e) Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity: this is normally upon notification of the interest paid or payable by the bank.
9
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
f) Funds accounting
Unrestricted funds are available to spend on activities that further any of the purposes of the charity. Designated funds are unrestricted funds of the charity which the trustees have decided at their discretion to set aside to use for a specific purpose. Restricted funds are donations which the donor has specified are to be solely used for particular areas of the charity's work or for specific projects being undertaken by the charity.
g) Expenditure and irrecoverable VAT
Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably.
Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.
h) Allocation of support and governance costs
Support and governance costs are those functions that assist the work of the charity but do not directly undertake charitable activities. These costs have been allocated in full to expenditure on charitable activities which is deemed to be reflective of the activities of the charity in this period.
i) Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
j) Cash at bank and in hand
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
k) Creditors
Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
l) Financial instruments
The charitable company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently recognised at amortised cost using the effective interest method.
m) Pension costs
The company operates a defined contribution pension scheme for its employees. There are no further liabilities other than that already recognised in the SOFA.
n) Foreign currency transactions
Transactions in foreign currencies are translated at rates prevailing at the date of the transaction. Balances denominated in foreign currencies are translated at the rate of exchange prevailing at the year end.
10
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
o) Accounting estimates and key judgements
In the application of the charity's accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
There were no sources of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements during the year.
2. Prior period comparatives: statement of financial activities
| Income from: Donations and legacies Charitable activities Investments Total income Expenditure on: Raising funds Charitable activities Total expenditure Net income / (expenditure) and net movement in funds |
Restricted £ £ 111,499 345,260 - 1,798 - 153 111,499 347,211 - 10,469 114,273 248,408 114,273 258,877 (2,774) 88,334 Unrestricted |
2022 Total £ 456,759 1,798 153 |
|---|---|---|
| 458,710 | ||
| 10,469 362,681 |
||
| 373,150 | ||
| 85,560 |
11
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
3. Income from donations
| Income from donations | ||
|---|---|---|
| Grants Esmee Fairbairn Foundation Glass House Trust John Ellerman Foundation OSF Global Fund Trust for London University of Bristol Brigstow Institute Donations Other donations Total from donations Prior period comparative Grants Esmee Fairbairn Foundation Glass House Trust John Ellerman Foundation OSF Global Fund Trust for London Tudor Trust Donations Other donations Gifts in kind Total from donations* |
Restricted £ £ - 55,000 - 1,500 40,000 - - 152,312 42,000 - 1,260 - 902 - 7,665 57,852 91,827 266,664 Restricted £ £ - 50,000 - 15,000 40,000 - - 146,628 20,000 - 50,000 - 1,499 128,632 - 5,000 111,499 345,260 Unrestricted Unrestricted |
2023 Total £ 55,000 1,500 40,000 152,312 42,000 1,260 902 65,517 |
| 358,491 | ||
| 2022 Total £ 50,000 15,000 40,000 146,628 20,000 50,000 130,131 5,000 |
||
| 456,759 |
*Gifts in kind for 2022 represent a one off donation of a converted ambulance used to educate the public on overdose prevention centres.
12
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
4. Income from charitable activities
| Income from charitable activities | ||
|---|---|---|
| Consultancy Event income Sales of merchandise Total income from charitable activities |
2023 Total £ 3,300 676 - 3,976 |
2022 Total £ 1,740 - 58 |
| 1,798 |
All income from charitable activities in the current and prior year was unrestricted.
5. Total expenditure
| Staff costs (note 7) Training and recruitment Postage and stationery Printing and design Subscriptions, licences and charges Travel and subsistence Event costs Digital productions Equipment and software Legal and professional Office costs Rent, rates and utilities Insurance Accountancy Bank charges Sub-total Allocation of support and governance costs Total expenditure |
Raising funds £ 12,543 - - - - - - - - 197 - - - - - 12,740 - 12,740 |
Charitable activities £ 266,290 1,445 - 4,915 - 3,074 46,965 3,110 - 4,975 - - - - - 330,774 70,874 401,648 |
£ 20,195 - 1,785 - 2,940 - - - 5,968 8,595 5,702 11,369 2,199 11,827 294 70,874 (70,874) - Support and governance costs |
2023 Total £ 299,028 1,445 1,785 4,915 2,940 3,074 46,965 3,110 5,968 13,767 5,702 11,369 2,199 11,827 294 |
|---|---|---|---|---|
| 414,388 - |
||||
| 414,388 |
Total governance costs were £1,980 (2022: £1,800).
13
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
| 5. Total expenditure (continued) Prior period comparative Staff costs (note 7) Training and recruitment Postage and stationery Printing and design Subscriptions, licences and charges Travel and subsistence Event costs Digital productions Equipment and software Legal and professional Office costs Rent, rates and utilities Insurance Accountancy Bank charges Sub-total Allocation of support and governance costs Total expenditure |
Raising funds £ 10,469 - - - - - - - - - - - - - - 10,469 - 10,469 |
Charitable activities £ 237,845 3,470 - 9,890 3,216 2,184 19,429 13,511 - 400 - - - - - 289,945 72,736 362,681 |
2022 Total £ £ 15,786 264,100 - 3,470 2,374 2,374 - 9,890 4,800 8,016 - 2,184 - 19,429 - 13,511 10,650 10,650 13,831 14,231 1,156 1,156 19,003 19,003 1,868 1,868 3,035 3,035 233 233 72,736 373,150 (72,736) - - 373,150 Support and governance costs |
|---|---|---|---|
14
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
6. Net movement in funds
This is stated after charging:
| Trustees' remuneration Trustees' reimbursed expenses Independent examiner's remuneration: Independent examination (excluding VAT) |
2023 £ Nil Nil 1,650 |
2022 £ Nil Nil 1,500 |
|---|---|---|
7. Staff costs and numbers Staff costs were as follows:
| Salaries and wages Social security costs Pension costs |
2023 £ 264,132 22,087 12,809 299,028 |
2022 £ 234,645 18,960 10,495 |
|---|---|---|
| 264,100 |
One employee earned more than £60,000 during the year (2022: none).
The key management personnel of the charitable company comprise the Trustees and the Chief Executive Officer. The total employee benefits of the key management personnel were £70,458 (2022: £56,255).
| Average head count | 2023 No. 9 |
2022 No. 8 |
|---|---|---|
8. Taxation
The charity is exempt from corporation tax as all its income is charitable and is applied for charitable purposes.
15
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
| For the year ended 31 March 2023 | |||
|---|---|---|---|
| 9. Debtors Prepayments Other debtors 10. Creditors: amounts due within 1 year Trade creditors Accruals Other taxation and social security Other creditors 11. Analysis of net assets between funds Restricted funds £ Current assets 52,373 Current liabilities (1,660) Net assets at 31 March 2023 50,713 Prior year comparative Restricted funds £ Current assets 90,331 Current liabilities (15,438) Net assets at 31 March 2022 74,893 |
Designated funds £ 321,302 - 321,302 Designated funds £ 292,670 - 292,670 |
2023 £ 1,055 3,973 5,028 2023 £ 2,347 6,290 6,209 1,840 16,686 General funds £ 26,811 (15,026) 11,785 General funds £ 130,426 (63,019) 67,407 |
2022 £ 4,674 265 |
| 4,939 | |||
| 2022 £ 58,907 11,056 6,643 1,851 |
|||
| 78,457 | |||
| Total funds £ 400,486 (16,686) |
|||
| 383,800 | |||
| Total funds £ 513,427 (78,457) |
|||
| 434,970 |
16
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
12. Movements in funds
| Restricted funds Anyone's Child Trust for London University of Bristol Brigstow Institute Total restricted funds Designated funds: OSF Esmee Fairbairn Foundation Reserves fund Trustee donation Total designated funds General funds Total unrestricted funds Total funds Unrestricted funds |
At 1 April 2022 £ 74,893 - - - 74,893 120,000 16,670 126,000 30,000 292,670 67,407 360,077 434,970 |
Income £ 47,665 42,000 1,260 902 91,827 152,312 55,000 - - 207,312 64,079 271,391 363,218 |
£ (87,247) (26,598) (1,260) (902) (116,007) (120,000) (51,666) - (7,014) (178,680) (119,701) (298,381) (414,388) Expenditure |
£ £ - 35,311 - 15,402 - - - - - 50,713 - 152,312 - 20,004 - 126,000 - 22,986 - 321,302 - 11,785 - 333,087 - 383,800 Transfers between funds At 31 March 2023 |
£ £ - 35,311 - 15,402 - - - - - 50,713 - 152,312 - 20,004 - 126,000 - 22,986 - 321,302 - 11,785 - 333,087 - 383,800 Transfers between funds At 31 March 2023 |
|---|---|---|---|---|---|
| 50,713 | |||||
| 152,312 20,004 126,000 22,986 |
|||||
| 321,302 | |||||
| 11,785 | |||||
| 333,087 | |||||
| 383,800 |
Purposes of restricted funds Anyone's Child
The Anyone's Child project, funded by the Tudor Trust and the John Ellerman Foundation, aims to enable families impacted by current drug policy to speak out.
Trust for London
Money received from the Trust for London to supported an allyship between Transform Drug Policy Foundation and Blaksox, which seeks to amplify the voices of Black communities in the drug policy debate.
University of Bristol
This funding is to work in partnership with academics from Bristol University to explore how to best tell challenging and sensitive stories around drugs in the city.
Brigstow Institute
This is funding to employ an intern to support Transform and the Anyone's Child campaign.
17
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
12. Movements in funds (continued) Purposes of designated funds
Open Society Foundation
The Open Society Foundation provide an annual grant to fund charitable operations, with the current grant running until July 2024.
Esmee Fairbairn Foundation
The Esmee Fairbairn Foundation grant funds the charity's core work in the UK, i.e. education, research and advocacy.
Reserves fund
The reserves fund exists to protect the charity against any sudden unexpected drop in funding. It is calculated to cover three months' running costs, plus the potential cost of staff redundancies and other contractual liabilities in the event of the charity being wound up.
Trustee donation
This donation has been designated for some work focusing on Christian Ethics and drug policy reform, including an event at St George’s House and a report.
| Prior year comparative Restricted funds Anyone's Child Trust for London Total restricted funds Designated funds: OSF Esmee Fairbairn Foundation CAF America Reserves fund Dilapidations fund Trustee donation Total designated funds General funds Total unrestricted funds Total funds Unrestricted funds |
At 1 April 2021 £ 57,667 20,000 77,667 44,472 18,754 24,462 126,000 8,000 - 221,688 50,055 271,743 349,410 |
Income £ 91,499 20,000 111,499 146,628 50,000 - - - - 196,628 150,583 347,211 458,710 |
£ (74,273) (40,000) (114,273) (71,100) (52,084) (24,462) - - - (147,646) (111,231) (258,877) (373,150) Expenditure |
£ £ - 74,893 - - - 74,893 - 120,000 - 16,670 - - - 126,000 (8,000) - 30,000 30,000 22,000 292,670 (22,000) 67,407 - 360,077 - 434,970 Transfers between funds At 31 March 2022 |
£ £ - 74,893 - - - 74,893 - 120,000 - 16,670 - - - 126,000 (8,000) - 30,000 30,000 22,000 292,670 (22,000) 67,407 - 360,077 - 434,970 Transfers between funds At 31 March 2022 |
|---|---|---|---|---|---|
| 74,893 | |||||
| 120,000 16,670 - 126,000 - 30,000 |
|||||
| 292,670 | |||||
| 67,407 | |||||
| 360,077 | |||||
| 434,970 |
18
Transform Drug Policy Foundation
Notes to the financial statements
For the year ended 31 March 2023
13. Related party transactions
The total aggregate donations from trustees during the year were £25,000 towards general costs of running Transform Drug Policy Foundation (2022: £60,000).
The trustees are not aware of any further related party transactions during the current or prior year.
19